
Sorry, the comment form is closed at this time.
Boston University researchers, led by Drs. George J. Murphy and Martin Steinberg, have developed a way to test treatments for sickle cell disease – a genetic disorder of the blood – by working with pluripotent stem cells grown from a small amount of the patient’s own blood. Click on the picture to link to the full article.
Amy Leung, Ph.D, a postdoctoral fellow in the Murphy Lab was awarded a prestigious research award following the presentation of her work at the International Symposium on Amyloidosis in Groningen, The Netherlands, 6-10 May 2012.
More Than Just Skin Deep: Read more about the CReM Directors by clicking on this link…
“Induced Pluripotent Stem Cell Modeling of Human Hereditary Amyloidosis”
This project will generate a new form of stem cells that start out as skin or blood cells but are then reprogrammed into cells that have the ability to become any type of tissue in the body. These stem cells will be utilized to study a genetic disease through the directed differentiation of these cells in vitro in order to recapitulate the outcome of the disease. Possible benefits of this research are new ways to study treatments for genetic diseases such as familial amyloidosis.
CLICK ON THE ICON TO LEARN MORE…